IRIS PubliCatt

Bria, Emilio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.425
EU - Europa 1.737
AS - Asia 473
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
SA - Sud America 2
Totale 4.677
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.407
SE - Svezia 564
IT - Italia 406
CN - Cina 185
IE - Irlanda 176
SG - Singapore 144
PL - Polonia 141
FR - Francia 121
DE - Germania 100
IN - India 67
RU - Federazione Russa 67
GB - Regno Unito 49
CI - Costa d'Avorio 29
IR - Iran 21
FI - Finlandia 20
CZ - Repubblica Ceca 18
BE - Belgio 17
HK - Hong Kong 16
UA - Ucraina 15
CA - Canada 13
ES - Italia 10
TR - Turchia 10
VN - Vietnam 10
CH - Svizzera 9
NL - Olanda 8
KR - Corea 5
EU - Europa 4
HU - Ungheria 3
IL - Israele 3
JP - Giappone 3
NO - Norvegia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AU - Australia 2
BR - Brasile 2
DO - Repubblica Dominicana 2
HN - Honduras 2
LV - Lettonia 2
SA - Arabia Saudita 2
TW - Taiwan 2
AT - Austria 1
BG - Bulgaria 1
GR - Grecia 1
IQ - Iraq 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MX - Messico 1
NG - Nigeria 1
OM - Oman 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 4.677
Salva come PNG Salva come JPEG
Città #
Chandler 550
Ashburn 258
Dublin 169
Fairfield 161
Warsaw 141
Wilmington 98
Rome 95
Princeton 91
Singapore 89
San Mateo 84
New York 79
Houston 72
Seattle 62
Milan 59
Boston 56
Woodbridge 55
Moscow 54
Cambridge 47
Ann Arbor 43
Cattolica 41
Marseille 40
Beijing 38
Boardman 37
Chicago 33
Abidjan 29
Bremen 29
Redwood City 25
Dearborn 23
Nanjing 22
London 18
Helsinki 17
Augusta 16
Brussels 16
Andover 15
Brno 14
Jacksonville 14
Redmond 14
Hong Kong 13
Kish 13
Norwalk 13
Nanchang 11
San Diego 10
Busto Arsizio 9
Dong Ket 9
Hangzhou 9
Los Angeles 8
Bengaluru 7
Paris 7
Pune 7
Izmir 6
Leawood 6
Madrid 6
Padova 6
Washington 6
Bari 5
Hebei 5
Hefei 5
Mountain View 5
Munich 5
Seoul 5
Zurich 5
Bern 4
Caserta 4
Duncan 4
Florence 4
Frankfurt am Main 4
Guangzhou 4
Montepulciano 4
Sacramento 4
Tianjin 4
Toronto 4
Acton 3
Addison 3
Amsterdam 3
Berlin 3
Budapest 3
Chions 3
Dallas 3
Edinburgh 3
Hyderabad 3
Jiaxing 3
Jinan 3
Kunming 3
Lanzo d'Intelvi 3
Lappeenranta 3
Palermo 3
Prague 3
Shenyang 3
Verona 3
Arezzo 2
Atlanta 2
Azzano Decimo 2
Bassano del Grappa 2
Binetto 2
Burlington 2
Cardano 2
Chiswick 2
Clearwater 2
Desio 2
Esslingen am Neckar 2
Totale 3.001
Salva come PNG Salva come JPEG
Nome #
Pembrolizumab as first-line treatment for metastatic uveal melanoma 265
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations 193
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 193
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 156
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 115
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 98
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 88
191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis 86
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 83
[Use of the Lean methodology in the management of cancer patients in a University Hospital, Italy: First results] 74
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 73
[Use of the Lean methodology in the management of cancer patients in a University Hospital, Italy: First results] 72
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 71
Body composition changes in gastric cancer patients during preoperative flot therapy: Preliminary results of an italian cohort study 70
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges. 68
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study 67
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 66
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 65
Radiotherapy benefit in oligoprogressive breast cancer: A retrospective analysis 65
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 63
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 63
The facts about food after cancer diagnosis: A systematic review of prospective cohort studies 62
Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis. 60
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 60
Effects of nutritional interventions on nutritional status in patients with gastric cancer: A systematic review and meta-analysis of randomized controlled trials 59
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in er+/her2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 59
Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment 58
Evidence-based tailored nutrition educational intervention improves adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: A prospective interventional study 53
Exploring the molecular and biological background of lung neuroendocrine tumours 52
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 52
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analisys 52
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 51
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 51
Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis 50
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 50
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: A systematic review and meta-analysis 49
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 49
Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients’ data from 3 phase III studies 49
Masaoka-koga and tnm staging system in thymic epithelial tumors: Prognostic comparison and the role of the number of involved structures 49
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 48
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study 48
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 47
Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinoma 47
Advances towards the design and development of personalized non-small-cell lung cancer drug therapy 46
Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-Analysis 46
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 45
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors 45
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 45
Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives 45
Prognostic factors and long-term survival in locally advanced nsclc with pathological complete response after surgical resection following neoadjuvant therapy 44
External validation of the N descriptor in the proposed tumour-node-metastasis subclassification for lung cancer: The crucial role of histological type, number of resected nodes and adjuvant therapy 44
Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy 43
PD-L1 Expression in de Novo Metastatic Castration-sensitive Prostate Cancer 43
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis 41
Collagenous colitis and atezolizumab therapy: an atypical case. 41
Survival analysis in single N2 station lung adenocarcinoma: The prognostic role of involved lymph nodes and adjuvant therapy 40
Advances towards the design and development of personalized non-small-cell lung cancer drug therapy 36
Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors 35
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 33
Nutritional Support in Lung Cancer Patients: The State of the Art 33
ALK gene copy number gains in non-small-cell lung cancer: Prognostic impact and clinico-pathological correlations 30
Differential activity of nivolumab, pembrolizumab and MPDL3280A according to the tumor expression of programmed death-ligand-1 (PD-L1): Sensitivity analysis of trials in melanoma, lung and genitourinary cancers 30
Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients 29
PTEN in colorectal cancer: Shedding light on its role as predictor and target 29
Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer 28
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer 27
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 27
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 25
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study 24
Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report 22
Muscle derangement and alteration of the nutritional machinery in NSCLC 21
Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: A multicentre analysis 21
Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non-Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial 21
Bronchoscopically-visible massive central airway cancer cavitation is associated with metastatic disease, lack of actionable mutations and poor prognosis: a case series 18
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analysis 18
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma 18
Interfering with CCL5/CCR5 at the Tumor-Stroma Interface 18
Tracking MET de-addiction in lung cancer: A road towards the oncogenic target 18
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: Prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer 18
Predictive and prognostic effect of computed tomography-derived body composition analysis during neoadjuvant chemotherapy for operable and locally advanced breast cancer 17
Revising PTEN in the era of immunotherapy: New perspectives for an old story 17
Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival 17
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 17
Hyperprogressive Disease in Patients with Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors or with Single-Agent Chemotherapy 17
Patients’ perception of chemotherapy side effects: Expectations, doctor–patient communication and impact on quality of life – An Italian survey 17
Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 17
Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative Results 16
Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1–T3, N0–N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study 16
PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: Pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab 16
Cryoablation in Locoregional Management of Complex Unresectable Chest Neoplasms 15
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics 15
Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial 15
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC) 15
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced nonsmall cell lung cancer 14
Role of Peripheral Blood Markers for Detecting Response and Predicting Prognosis in Patients with Non-small-cell Lung Cancer Undergoing Neoadjuvant Therapy and Surgery 14
Unmasking the impact of Rictor in cancer: Novel insights of mTORC2 complex 14
International experts panel meeting of the Italian association of thoracic oncology on antiangiogenetic drugs for non-small cell lung cancer: Realities and hopes 14
Prognostic score for survival with pulmonary carcinoids: The importance of associating clinical with pathological characteristics 14
Is Surgery Worthwhile in Locally-advanced NSCLC Patients with Persistent N2-disease After Neoadjuvant Therapy? 14
Loss of FGFR4 promotes the malignant phenotype of PDAC 13
Totale 4.720
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.453
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020494 0 25 42 90 22 37 53 19 30 11 133 32
2020/2021462 24 27 50 39 85 17 40 3 45 44 62 26
2021/2022914 107 39 18 101 37 38 23 139 48 27 157 180
2022/20231.699 266 207 134 241 75 201 99 125 176 57 67 51
2023/20241.055 36 250 39 49 41 114 108 53 17 56 128 164
2024/202592 88 4 0 0 0 0 0 0 0 0 0 0
Totale 4.854